Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Carica papaya L.: A Tropical Fruit with Benefits beyond the Tropics

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60076658%3A12220%2F22%3A43910869" target="_blank" >RIV/60076658:12220/22:43910869 - isvavai.cz</a>

  • Výsledek na webu

    <a href="https://www.mdpi.com/1424-2818/14/8/683" target="_blank" >https://www.mdpi.com/1424-2818/14/8/683</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.3390/d14080683" target="_blank" >10.3390/d14080683</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Carica papaya L.: A Tropical Fruit with Benefits beyond the Tropics

  • Popis výsledku v původním jazyce

    Carica papaya L. (family: Caricaceae), also known as &apos;papaya,&apos; is a tropical American fruit tree. Due to the bioactive components (carpaines, BITC, benzyl glucosinolates, latex, papain, zeaxanthin, choline, etc.) in its seeds, leaves, and fruits, it is revered for its excellent antioxidant, digestive, and nutraceutical benefits. Papayas are high in vitamins A, B, C, E, and K, folate, pantothenic acid, zeaxanthin, lycopene, lutein, magnesium, copper, calcium, and potassium. Being rich in fiber, antioxidants, and vitamin C, it lowers the cholesterol in the arteries; prevents arthritis; reduces aging, cancer, macular degradation, risk of cardiovascular diseases, and stress; increases platelet count; controls dengue fever; facilitates digestion, and lowers body weight. Papaya leaf extract, with many in vitro and case studies in combination therapies with modern medicine, especially for cancers and many other viral diseases, has been found to be an efficient cure. Humans have cultivated papaya cultivars for millions of years because of their significant commercial, medicinal, and agronomic value. Several reports have been published on the genetic modification of papaya for resistance to abiotic (herbicide, Al toxicity, etc.) and biotic stressors (PRSV, mites, Phytophthora, etc.), delaying ripening, and improving shelf life. However, most of these traits have not been introduced globally to all commercial papaya varieties. Unraveling the genetics of papaya has shed light on various domestication impacts, evolutionary patterns, and sex determination in fruit tree crops. It also serves as a potential step toward developing new cultivars to fight climate-oriented stress. Furthermore, extensive research on the stability of the &apos;transgene&apos; across generations, and the &apos;yield-penalty&apos; caused by the transgene, is required. Thus, meticulous crop improvement research on commercial papaya cultivars is necessary for long-term food and health security. This review article encompasses information on the traditional and modern medicinal uses, nutritional properties, phytochemistry, diseases and etiology, post-harvest measures, genomics, biotechnological strategies (for papaya improvement), and value-added products of papaya for food and health security.

  • Název v anglickém jazyce

    Carica papaya L.: A Tropical Fruit with Benefits beyond the Tropics

  • Popis výsledku anglicky

    Carica papaya L. (family: Caricaceae), also known as &apos;papaya,&apos; is a tropical American fruit tree. Due to the bioactive components (carpaines, BITC, benzyl glucosinolates, latex, papain, zeaxanthin, choline, etc.) in its seeds, leaves, and fruits, it is revered for its excellent antioxidant, digestive, and nutraceutical benefits. Papayas are high in vitamins A, B, C, E, and K, folate, pantothenic acid, zeaxanthin, lycopene, lutein, magnesium, copper, calcium, and potassium. Being rich in fiber, antioxidants, and vitamin C, it lowers the cholesterol in the arteries; prevents arthritis; reduces aging, cancer, macular degradation, risk of cardiovascular diseases, and stress; increases platelet count; controls dengue fever; facilitates digestion, and lowers body weight. Papaya leaf extract, with many in vitro and case studies in combination therapies with modern medicine, especially for cancers and many other viral diseases, has been found to be an efficient cure. Humans have cultivated papaya cultivars for millions of years because of their significant commercial, medicinal, and agronomic value. Several reports have been published on the genetic modification of papaya for resistance to abiotic (herbicide, Al toxicity, etc.) and biotic stressors (PRSV, mites, Phytophthora, etc.), delaying ripening, and improving shelf life. However, most of these traits have not been introduced globally to all commercial papaya varieties. Unraveling the genetics of papaya has shed light on various domestication impacts, evolutionary patterns, and sex determination in fruit tree crops. It also serves as a potential step toward developing new cultivars to fight climate-oriented stress. Furthermore, extensive research on the stability of the &apos;transgene&apos; across generations, and the &apos;yield-penalty&apos; caused by the transgene, is required. Thus, meticulous crop improvement research on commercial papaya cultivars is necessary for long-term food and health security. This review article encompasses information on the traditional and modern medicinal uses, nutritional properties, phytochemistry, diseases and etiology, post-harvest measures, genomics, biotechnological strategies (for papaya improvement), and value-added products of papaya for food and health security.

Klasifikace

  • Druh

    J<sub>imp</sub> - Článek v periodiku v databázi Web of Science

  • CEP obor

  • OECD FORD obor

    40106 - Agronomy, plant breeding and plant protection; (Agricultural biotechnology to be 4.4)

Návaznosti výsledku

  • Projekt

  • Návaznosti

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Ostatní

  • Rok uplatnění

    2022

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    Diversity-Basel

  • ISSN

  • e-ISSN

    1424-2818

  • Svazek periodika

    14

  • Číslo periodika v rámci svazku

    8

  • Stát vydavatele periodika

    CH - Švýcarská konfederace

  • Počet stran výsledku

    33

  • Strana od-do

    "2022/08/20"

  • Kód UT WoS článku

    000846114400001

  • EID výsledku v databázi Scopus